Stay updated on XMT-1536 First-in-Human Study in NaPi2b-Expressing Cancers Clinical Trial

Sign up to get notified when there's something new on the XMT-1536 First-in-Human Study in NaPi2b-Expressing Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the XMT-1536 First-in-Human Study in NaPi2b-Expressing Cancers Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-06T19:04:10.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    35 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.1 to v3.4.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-13T11:52:36.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision: v3.4.1 is now displayed, replacing the previous v3.4.0.
    Difference
    0.1%
    Check dated 2026-02-05T17:16:11.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Added a 'Show glossary' option and updated metadata: 'Last Update Submitted that Met QC Criteria' capitalization adjusted, 'No FEAR Act Data' added, and the Revision updated to v3.4.0 (replacing v3.3.4).
    Difference
    0.2%
    Check dated 2026-01-29T06:58:42.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4. No study content, eligibility criteria, or results were modified.
    Difference
    0.1%
    Check dated 2026-01-15T02:45:47.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    Added a Locations section with Oklahoma as a trial site. This updates where the study is recruiting and participating locations are shown.
    Difference
    0.2%
    Check dated 2025-12-23T14:22:19.000Z thumbnail image

Stay in the know with updates to XMT-1536 First-in-Human Study in NaPi2b-Expressing Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the XMT-1536 First-in-Human Study in NaPi2b-Expressing Cancers Clinical Trial page.